The sphingomyelin pathway is a ubiquitous, evolutionarily conserved signaling system initiated by hydrolysis of the plasma membrane phospholipid sphingomyelin to generate ceramide. A number of direct targets for ceramide signaling have now been identified. Ceramide-activated protein (CAP) kinase is a membrane-bound, 97 kD Ser/Thr proline-directed protein kinase. Although the full range of activities of CAP kinase is as yet unknown, recent studies suggested it signals the proinflammatory action of TNFa via activating Raf-l. Dr. Kolesnick and his colleagues reported that CAP kinase complexes with, phosphorylates and stimulates Raf-1 in a ceramide- and TNF-dependent manner. While Raf-1 activation involves binding to GTP-ras, recent studies identified the existence of a kinase suppressor of ras (KSR). The investigators have identified KSR as CAP kinase. The present application extends these observations and examines the mechanism of signal transduction through KSR/CAP kinase.
The specific aims of this application are: (1) The development of reagents for studying the extent of expression and biologic relevance of KSR/CAP kinase in mammalian cells. (2) The identification of KSR]CAP kinase domains involved in Raf-1 activation. (3) The characterization of proximal elements (ceramide, tyrosine kinases, endotoxin, ras) in KSR/CAP kinase activation. These studies will likely impact three distinct areas of cell biologic research. The demonstration of alternatives to the classic signaling systems for Raf-1 activation should provide a basis for new investigations into the role of Raf-1 in various cellular responses, including inflammation, proliferation and regulation of apoptosis. The availability of CAP kinase as a reagent should facilitate studies of mechanisms by which ceramide activates cellular targets to initiate transmembrane signaling. Lastly, the demonstration that KSR/CAP kinase may be integral to inflammatory signaling through the TNF receptor and should provide a foundation for studies into its role in the pathogenesis of TNF-mediated disease. It may also provide a biochemical target for pharmacologic manipulation of TNF action in vivo, with potential for clinical application.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Research Project (R01)
Project #
Application #
Study Section
Medical Biochemistry Study Section (MEDB)
Program Officer
Blair, Donald G
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Sloan-Kettering Institute for Cancer Research
New York
United States
Zip Code
Yin, Xianglei; Zafrullah, Mohammad; Lee, Hyunmi et al. (2009) A ceramide-binding C1 domain mediates kinase suppressor of ras membrane translocation. Cell Physiol Biochem 24:219-30
Zafrullah, Mohammad; Yin, Xianglei; Haimovitz-Friedman, Adriana et al. (2009) Kinase suppressor of Ras transphosphorylates c-Raf-1. Biochem Biophys Res Commun 390:434-40
Zhang, Jianjun; Zafrullah, Mohammad; Yang, Xia et al. (2008) Downregulation of KSR1 in pancreatic cancer xenografts by antisense oligonucleotide correlates with tumor drug uptake. Cancer Biol Ther 7:1490-5
Kolesnick, Richard (2002) The therapeutic potential of modulating the ceramide/sphingomyelin pathway. J Clin Invest 110:3-8
Liu, J; Mathias, S; Yang, Z et al. (1994) Renaturation and tumor necrosis factor-alpha stimulation of a 97-kDa ceramide-activated protein kinase. J Biol Chem 269:3047-52
Haimovitz-Friedman, A; Kan, C C; Ehleiter, D et al. (1994) Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med 180:525-35
Kolesnick, R (1994) Signal transduction through the sphingomyelin pathway. Mol Chem Neuropathol 21:287-97
Mathias, S; Kolesnick, R (1993) Ceramide: a novel second messenger. Adv Lipid Res 25:65-90
Joseph, C K; Byun, H S; Bittman, R et al. (1993) Substrate recognition by ceramide-activated protein kinase. Evidence that kinase activity is proline-directed. J Biol Chem 268:20002-6
Mathias, S; Younes, A; Kan, C C et al. (1993) Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1 beta. Science 259:519-22

Showing the most recent 10 out of 29 publications